Articles with "cardiovascular benefits" as a keyword



Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.40117

Abstract: This cross-sectional study evaluates the variations in use of diabetes drugs with cardiovascular benefits among Medicaid patients. read more here.

Keywords: diabetes drugs; variations use; use diabetes; benefits among ... See more keywords
Photo from wikipedia

Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes.

Sign Up to like & get
recommendations!
Published in 2022 at "Primary care diabetes"

DOI: 10.1016/j.pcd.2022.03.012

Abstract: Given the CV benefit noted in the CVOTs, GLP-1RAs and SGLT-2is are given preference in T2DM guidelines. While guidelines do not report potential gender difference, those differences exist. On restricting the CVOTs results to women… read more here.

Keywords: diabetes cardiovascular; sglt women; glp 1ra; 1ra sglt ... See more keywords

SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits

Sign Up to like & get
recommendations!
Published in 2024 at "Cardiovascular Research"

DOI: 10.1093/cvr/cvae047

Abstract: Abstract An increasing number of individuals are at high risk of type 2 diabetes (T2D) and its cardiovascular complications, including heart failure (HF), chronic kidney disease (CKD), and eventually premature death. The sodium-glucose co-transporter-2 (SGLT2)… read more here.

Keywords: cardiovascular benefits; sglt2 inhibitors; glucose lowering; inhibitors glucose ... See more keywords
Photo by nci from unsplash

Cardiovascular benefits and risks of testosterone replacement: another warning?

Sign Up to like & get
recommendations!
Published in 2017 at "Cardiovascular Research"

DOI: 10.1093/cvr/cvx143

Abstract: Although testosterone (T) replacement is increasingly being used clinically, cardiovascular benefits and risks of T administration to older men with age-related decline in T levels remain uncertain. The WHI randomized trial reporting potential harmful coronary… read more here.

Keywords: risks testosterone; replacement another; testosterone replacement; cardiovascular benefits ... See more keywords

A review of cardiovascular benefits of SGLT2 inhibitors.

Sign Up to like & get
recommendations!
Published in 2022 at "Medicine"

DOI: 10.1097/md.0000000000030310

Abstract: Sodium-glucose cotransporter 2 inhibitor (SGLT2I) is a new type of hypoglycemic drug that targets the kidney. As research continues to advance on this topic, it has been found that SGLT2I has multiple protective effects, such… read more here.

Keywords: sglt2 inhibitors; review cardiovascular; cardiovascular benefits; benefits sglt2 ... See more keywords

Abstract 4113486: Cardiovascular Benefits of Sotagliflozin in Diabetic Populations: A Meta-Analysis

Sign Up to like & get
recommendations!
Published in 2024 at "Circulation"

DOI: 10.1161/circ.150.suppl_1.4113486

Abstract: Background: Sotagliflozin, an inhibitor of both SGLT1 and SGLT2, is under investigation for potential cardioprotective effects in diabetic patients. Aims: This study assesses the efficacy and cardiovascular benefits of sotagliflozin in patients with type 1… read more here.

Keywords: reduction; meta analysis; cardiovascular benefits; benefits sotagliflozin ... See more keywords

Unbreak my heart: macrolide cardiovascular benefits and safety in bronchiectasis

Sign Up to like & get
recommendations!
Published in 2025 at "European Respiratory Journal"

DOI: 10.1183/13993003.00045-2025

Abstract: Extract Long term macrolide treatment is recommended for patients with bronchiectasis who have frequent exacerbations despite regular airway clearance [1–3] and treatment of the underlying cause, where possible [4]. Shareable abstract Macrolides reduce exacerbations in… read more here.

Keywords: macrolide; cardiovascular benefits; bronchiectasis; unbreak heart ... See more keywords

Cardiovascular Benefits of Extended-Time Nocturnal Hemodialysis.

Sign Up to like & get
recommendations!
Published in 2020 at "Current vascular pharmacology"

DOI: 10.2174/1570161118666200401112106

Abstract: Hemodialysis (HD) remains the most utilized treatment for End Stage Kidney Disease (ESKD) globally, mainly as conventional HD administered in 4 h sessions thrice weekly. Despite advances in HD delivery, patients with ESKD carry a… read more here.

Keywords: hemodialysis; time; physiology; benefits extended ... See more keywords

Exploring the Cardiovascular Benefits of Extra Virgin Olive Oil: Insights into Mechanisms and Therapeutic Potential

Sign Up to like & get
recommendations!
Published in 2025 at "Biomolecules"

DOI: 10.3390/biom15020284

Abstract: Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide, driven by complex interactions among genetic, environmental, and lifestyle factors, with diet playing a pivotal role. Extra Virgin Olive Oil (EVOO), a cornerstone of the… read more here.

Keywords: extra virgin; cardiovascular benefits; therapeutic potential; virgin olive ... See more keywords
Photo by nci from unsplash

Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function

Sign Up to like & get
recommendations!
Published in 2021 at "Biomedicines"

DOI: 10.3390/biomedicines9101356

Abstract: Type 2 diabetes mellitus (T2DM) is a known independent risk factor for atherosclerotic cardiovascular disease (CVD) and solid epidemiological evidence points to heart failure (HF) as one of the most common complications of diabetes. For… read more here.

Keywords: effects endothelial; endothelial function; gliflozins effects; benefits gliflozins ... See more keywords

Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland

Sign Up to like & get
recommendations!
Published in 2021 at "International Journal of Molecular Sciences"

DOI: 10.3390/ijms22147684

Abstract: Heart failure (HF) remains the leading cause of morbidity and death in the western world, and new therapeutic modalities are urgently needed to improve the lifespan and quality of life of HF patients. The sodium-glucose… read more here.

Keywords: sglt2 inhibitors; blood glucose; sympatholytic effects; hypothesis ... See more keywords